Evelina Suraci

663 total citations
30 papers, 493 citations indexed

About

Evelina Suraci is a scholar working on Surgery, Epidemiology and Gastroenterology. According to data from OpenAlex, Evelina Suraci has authored 30 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Epidemiology and 7 papers in Gastroenterology. Recurrent topics in Evelina Suraci's work include Helicobacter pylori-related gastroenterology studies (9 papers), Inflammatory Bowel Disease (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Evelina Suraci is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (9 papers), Inflammatory Bowel Disease (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Evelina Suraci collaborates with scholars based in Italy, United States and Romania. Evelina Suraci's co-authors include Francesco Luzza, Maria Imeneo, Tiziana Larussa, Ludovico Abenavoli, R. Marasco, Marta Letizia Hribal, Teresa Vanessa Fiorentino, Giorgio Sesti, Antonio Procopio and Luigi Tucci and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Evelina Suraci

28 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evelina Suraci Italy	13	193	134	131	112	111	30	493
Maggie Ham United States	10	198 1.0×	141 1.1×	149 1.1×	66 0.6×	92 0.8×	13	566
Shuvra Ray United Kingdom	14	161 0.8×	154 1.1×	132 1.0×	21 0.2×	87 0.8×	33	456
Zhiqin Wong Malaysia	10	102 0.5×	164 1.2×	116 0.9×	46 0.4×	35 0.3×	27	453
Sender Jankiel Miszputen Brazil	14	121 0.6×	120 0.9×	197 1.5×	41 0.4×	80 0.7×	48	460
Marjan Mokhtare Iran	13	254 1.3×	79 0.6×	49 0.4×	203 1.8×	35 0.3×	54	554
Takuji Fujisawa Japan	13	352 1.8×	115 0.9×	30 0.2×	138 1.2×	71 0.6×	23	559
L. Folini Italy	7	116 0.6×	73 0.5×	184 1.4×	82 0.7×	45 0.4×	8	434
Mehrdad Dargahi-Malamir Iran	5	104 0.5×	136 1.0×	244 1.9×	40 0.4×	89 0.8×	15	627
Guila Abitbol Israel	10	308 1.6×	321 2.4×	495 3.8×	88 0.8×	55 0.5×	14	775
Esteban Sáez‐González Spain	11	124 0.6×	158 1.2×	222 1.7×	67 0.6×	92 0.8×	35	426

Countries citing papers authored by Evelina Suraci

Since Specialization

Citations

This map shows the geographic impact of Evelina Suraci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelina Suraci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelina Suraci more than expected).

Fields of papers citing papers by Evelina Suraci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evelina Suraci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelina Suraci. The network helps show where Evelina Suraci may publish in the future.

Co-authorship network of co-authors of Evelina Suraci

This figure shows the co-authorship network connecting the top 25 collaborators of Evelina Suraci. A scholar is included among the top collaborators of Evelina Suraci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelina Suraci. Evelina Suraci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abenavoli, Ludovico, Giuseppe Guido Maria Scarlata, Massimo Borelli, et al.. (2025). Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases. Journal of Clinical Medicine. 14(9). 2973–2973. 3 indexed citations

Suraci, Evelina, R. Marasco, Francesco Luzza, et al.. (2023). Association between higher duodenal levels of the fructose carrier glucose transporter‐5 and nonalcoholic fatty liver disease and liver fibrosis. Journal of Internal Medicine. 295(2). 171–180. 4 indexed citations

Fiorentino, Teresa Vanessa, Francesca De Vito, Evelina Suraci, et al.. (2023). Obesity and overweight are linked to increased sodium‐glucose cotransporter 1 and glucose transporter 5 levels in duodenum. Obesity. 31(3). 724–731. 13 indexed citations

Fiorentino, Teresa Vanessa, Francesca De Vito, Evelina Suraci, et al.. (2022). Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. Diabetes Research and Clinical Practice. 185. 109789–109789. 7 indexed citations

Larussa, Tiziana, Antonio Basile, Caterina Palleria, et al.. (2021). Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. Medicine and Pharmacy Reports. 94(3). 289–297. 7 indexed citations

Fiorentino, Teresa Vanessa, Evelina Suraci, Francesca De Vito, et al.. (2021). One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1. Diabetes Research and Clinical Practice. 181. 109094–109094. 3 indexed citations

Larussa, Tiziana, Ludovico Abenavoli, Anna Caterina Procopio, et al.. (2021). Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study.. PubMed. 25(10). 3752–3761. 3 indexed citations

Larussa, Tiziana, Evelina Suraci, R. Marasco, et al.. (2020). Barriers and Facilitators in Conducting Clinical Trials in Inflammatory Bowel Disease: A Monocentric Italian Survey. Reviews on Recent Clinical Trials. 15(2). 137–144. 10 indexed citations

Larussa, Tiziana, Evelina Suraci, R. Marasco, et al.. (2019). Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization. Medicina. 55(8). 507–507. 42 indexed citations

10.

Larussa, Tiziana, Marianna Rossi, Evelina Suraci, et al.. (2019). Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey. Medicina. 55(2). 46–46. 17 indexed citations

11.

Larussa, Tiziana, et al.. (2018). Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori. Journal of Immunology Research. 2018. 1–7. 20 indexed citations

12.

Larussa, Tiziana, Evelina Suraci, Marco Greco, et al.. (2017). P108 Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients. Journal of Crohn s and Colitis. 11(suppl_1). S130–S130.

13.

Larussa, Tiziana, Manuela Oliverio, Evelina Suraci, et al.. (2017). Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients. Nutrients. 9(4). 391–391. 70 indexed citations

14.

Larussa, Tiziana, et al.. (2015). Helicobacter pyloriand T Helper Cells: Mechanisms of Immune Escape and Tolerance. Journal of Immunology Research. 2015. 1–10. 90 indexed citations

15.

Larussa, Tiziana, Evelina Suraci, Teresa Procopio, et al.. (2014). Enhanced Expression of Indoleamine 2,3‐Dioxygenase in Helicobacter pylori‐Infected Human Gastric Mucosa Modulates Th1/Th2 Pathway and Interleukin 17 Production. Helicobacter. 20(1). 41–48. 24 indexed citations

16.

Abenavoli, Ludovico, Massimiliano Greco, Tiziana Larussa, et al.. (2013). P.11.3 METABOLIC EFFECTS OF DIET VS DIET AND SILYBIN COMBINED WITH PHOSPHATIDYLCHOLINE AND VITAMIN E IN OVERWEIGHT PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Digestive and Liver Disease. 45. S165–S166. 1 indexed citations

17.

Larussa, Tiziana, Evelina Suraci, Ludovico Abenavoli, et al.. (2012). High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. European Journal of Internal Medicine. 23(3). 273–277. 14 indexed citations

18.

Larussa, Tiziana, et al.. (2012). Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir. Gastroenterology Insights. 4(2). 19–19. 1 indexed citations

19.

Larussa, Tiziana, Evelina Suraci, Tiziana Montalcini, et al.. (2010). P.41 REDUCED BONE MINERAL DENSITY IS FREQUENT IN TREATED ADULT COELIAC DISEASE NOTWITHSTANDING COMPLETE NORMALIZATION OF DUODENAL LESIONS. Digestive and Liver Disease. 42. S117–S117. 1 indexed citations

20.

Larussa, Tiziana, Evelina Suraci, Ludovico Abenavoli, et al.. (2010). Short‐term Therapy with Celecoxib and Lansoprazole Modulates Th1/ Th2 Immune Response in Human Gastric Mucosa. Helicobacter. 15(5). 449–459. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact